Top Markets
Coin of the day
BriaCell Therapeutics Corp. BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp.

BCTX
Rankning i aktier #18277
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages... BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.
Aktiekurs
$4.34
Marknadsvärde
$8.17M
Förändring (1 dag)
-6.17%
Förändring (1 år)
-2.54%
Land
CA
Handel BriaCell Therapeutics Corp. (BCTX)

Kategori

Aktiekurshistorik för BriaCell Therapeutics Corp. (BCTX)
Högsta slutkurs: $4.42 den 2026-04-01

Lägsta slutkurs: $75.68 den 2012-08-01
Aktiekurshistorik för BriaCell Therapeutics Corp. från 2012 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) -39.84%
2025 1,135.43%
2024 -83.23%
2023 -12.56%
2022 -38.69%
2021 120.46%
2020 -59.87%
2019 -50.29%
2018 -42.32%
2017 -16.70%
2016 -13.38%
2015 9.99%
2014 82.35%
2013 -43.96%
2012 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$40.92 -34.92%
DK
$434.65 -10.55%
US
$746.82 35.96%
US
$306.86 95.16%
BE
$827.99 40.91%
NL